Group One Trading
SRRA

Group One Trading’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Group One Trading’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-250
Closed -$30K – 5789
2018
Q2 		$30K Hold
250
– – ﹤0.01% 4216
2018
Q1 		$21K Buy
+250
New +$28.3K ﹤0.01% 4077

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Group One Trading's SRRA Position: Q1 2022 in Review

Group One Trading sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2022, closing a stake of 212 shares — an estimated $6.08K sold.

Group One Trading first reported a position in SRRA in Q1 2018 and held it in 11 quarters. The position peaked at $30K in Q2 2018. 75 funds tracked by Wall St. Rank hold SRRA as of Q1 2022.

  • Group One Trading reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 212 Sierra Oncology, Inc. Common Stock shares in Q1 2022, an estimated $6.08K.
  • Group One Trading first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2018 and held it in 11 quarters.
  • Group One Trading's Sierra Oncology, Inc. Common Stock position peaked at $30K in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.